Contact Us
About Us
Our Company
Our Leadership
Global Collaborations
Areas of Focus
Vaccines
Other Diseases
Pipeline
Science & Technology
Our Technology
COVID-19 Response
Manufacturing
Publications
Careers
Our Culture
Our Benefits
Our Positions
Investors
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
News & Media
Company News
Media coverage
Contact Us
English
English
中文
Clover Biopharmaceuticals(HKEX: 2197)
Investor Relations
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
HKEX Filings
All Years
2024 (33)
2023 (41)
2022 (65)
2021 (23)
Search
Note: Please refer any disclosure documents of the listco to Hong Kong Stock Exchange (SEHK) website
Apr 23, 2021
Application Proof (1st submission)
Apr 23, 2021
Application Proof (1st submission)
<
5
6
7
8
9
About Us
Areas of Focus
Pipeline
Science & Technology
Careers
Investors
News & Media
Contact Us
Terms of Use
Privacy Policy
Community Guidelines
©2023 Clover Biopharmaceuticals
蜀ICP备08004531号-1
川公网安备51019002003830号